<style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style>
  • Using technology in tumor genomics to develop precision cancer therapeutics

    Investor Relations

SEC Filings

Trovagene is publicly traded on the NASDAQ stock exchange under the symbol TROV.

NASDAQTROV
FormDescriptionDateFormat
SC 13G/AAmendment to a previously filed SC 13GJan 9, 2018View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJan 8, 2018View HTMLDownload DOCDownload PDFDownload XLS
4/AAmendment to a previously filed 4Jan 4, 2018View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jan 4, 2018View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jan 4, 2018View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJan 3, 2018View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsDec 26, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 21, 2017View HTMLDownload DOCDownload PDFDownload XLS
424B4Form of prospectus disclosing information facts events covered in both forms 424B1 424B3Dec 15, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 15, 2017View HTMLDownload DOCDownload PDFDownload XLS
EFFECTNotice from the SEC of registration effectivenessDec 14, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 14, 2017View HTMLDownload DOCDownload PDFDownload XLS
S-1/AAmended Registration statement for face-amount certificate companiesDec 12, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 12, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 8, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 28, 2017View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-100      101-109

email print
3:34
3:34
Wistia video thumbnail - Susann-Berz Patient Video- Home Page

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?

Cancel
message